Global Immunohematology Market 2016-2020

Publisher Name :
Date: 28-Sep-2016
No. of pages: 99
Inquire Before Buying

About Immunohematology

Blood loss or anemia can lead to chronic health problems; therefore, clinicians performs blood transfusion that can help to get relief from chronic health problems. To transfuse, blood clinicians or hospitals take blood units present in their own integrated blood banks or from other centers. Immunohematology, also commonly known as blood banking, helps to screen the donor blood components for blood antigens, Rh factor, plasma, and white blood cell components. It helps to reduce blood transfusion-related diseases such as HIV and thalassemia. According to the guidelines by World Health Organization (WHO), donated blood is screened before it is transfused to protect the people from such fatalities in most of the countries.

This analyst forecast the global immunohematology market to grow at a CAGR of 4.79% during the period 2016-2020.

Covered in this report

This report covers the present scenario and the growth prospects of the global immunohematology market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of various immunohematology analyzers, systems, and reagents, which are used for transfusion medicine in blood banks and hospitals to screen the blood for molecular typing and serological test.

The market is divided into the following segments based on geography:

Americas

APAC

EMEA

The report, Global Immunohematology Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. This report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

Bio-Rad Laboratories

Grifols

Immucor

Ortho Clinical Diagnostics

Other prominent vendors

Agena Bioscience

BD

Beckman Coulter

biosurfit SA

Cardinal Health

DIAGAST

Hemo bioscience

Institut de Biotechnologies Jacques Boy

Lorne Laboratories

MTC INVITRO

Reagens

Seqirus

Tulip

Quotient

Market driver

Growing demand for blood banks and its potential to increase sales

For a full, detailed list, view our report

Market challenge

High maintenance cost and less reimbursement of blood components

For a full, detailed list, view our report

Market trend

Paradigm shift toward molecular immunohematology

For a full, detailed list, view our report

Key questions answered in this report

What will the market size be in 2020 and what will the growth rate be?

What are the key market trends?

What is driving this market?

What are the challenges to market growth?

Who are the key vendors in this market space?

What are the market opportunities and threats faced by the key vendors?

What are the strengths and weaknesses of the key vendors?

Global Immunohematology Market 2016-2020

Table of Contents

PART 01: Executive summary
Highlights
PART 02: Scope of the report
Market overview
Top-vendor offerings
PART 03: Market research methodology
Research methodology
Economic indicators
PART 04: Introduction
Key market highlights
Serologic test and its limitation
PART 05: Market landscape
Market overview
Market size and forecast
Five forces analysis
PART 06: Market segmentation by product
Global immunohematology market by analyzers and systems
Global immunohematology market by reagents
PART 07: Market segmentation by applications
Blood-related diseases
HIV
Hepatitis
PART 08: Market segmentation by end-users
Hospitals
Blood banks
Diagnostic laboratories
PART 09: Geographical segmentation
Immunohematology market in Americas
Immunohematology market in EMEA
Immunohematology market in APAC
PART 10: Market drivers
Paradigm shift of end-users toward automated immunohematology analyzer
Growing demand for blood banks and its potential to increase sales
Increasing sales through service-oriented sales organizations and GPOs
PART 11: Impact of drivers
PART 12: Market challenges
High maintenance cost and less reimbursement of blood components
Decrease in blood donors and medical guidelines reducing the sales of immunohematology analyzers
Operational challenge in blood screening and transfusion
PART 13: Impact of drivers and challenges
PART 14: Market trends
Increasing public and private funding to establish blood banks
Paradigm shift toward molecular immunohematology
Striving market growth through education and training program
PART 15: Vendor landscape
Competitive landscape analysis
Geographic presence: Key vendor analysis
Market share analysis
Bio-Rad Laboratories
Grifols
Immucor
Ortho Clinical Diagnostics
Other prominent vendors
PART 16: Appendix
List of abbreviations

List of Exhibits

Exhibit 01: Product offerings
Exhibit 02: Blood collection and transfusion by hospital services in US 2014
Exhibit 03: Accredited cord blood bank of AABB in various countries
Exhibit 04: Market overview: Global immunohematology market
Exhibit 05: Impact assessment of global immunohematology market 2015
Exhibit 06: Global immunohematology market 2015-2020 ($ billions)
Exhibit 07: Blood products sold in Finland in 2012-2014
Exhibit 08: Global immunohematology market scenarios: Revenue forecast 2015 and 2020 ($ billions)
Exhibit 09: Five forces analysis
Exhibit 10: Global immunohematology market by product 2015 and 2020 ($ millions)
Exhibit 11: Market overview: Global immunohematology market by analyzers and system
Exhibit 12: Immunohematology analyzer and system market in 2015-2020 ($ billions)
Exhibit 13: Market overview: Global immunohematology market by reagents
Exhibit 14: Immunohematology reagents market in 2015-2020 ($ millions)
Exhibit 15: Prevalence of cord blood transplantation for cancerous and non-cancerous blood diseases in 2014
Exhibit 16: Market overview: Blood-related diseases in global immunohematology market
Exhibit 17: Market overview: HIV in global immunohematology market
Exhibit 18: Global immunohematology market by end-users 2015
Exhibit 19: Americas: Country-specific market impact by hospitals
Exhibit 20: EMEA: Country-specific market impact by hospitals
Exhibit 21: APAC: Country-specific market impact by hospitals
Exhibit 22: Americas: Country-specific market impact by blood banks
Exhibit 23: EMEA: Country-specific market impact by blood banks
Exhibit 24: APAC: Country-specific market impact by blood banks
Exhibit 25: Transfusion of blood in different medical segments and their usage percentage in Singapore 2016
Exhibit 26: Global immunohematology market by geographical segmentation: 2015 and 2020 ($ millions)
Exhibit 27: Geographical segmentation of global immunohematology market by market share 2015-2020
Exhibit 28: Americas: Market overview of immunohematology
Exhibit 29: Americas: Prevalence of blood-borne infections 2013-2014
Exhibit 30: Immunohematology market in Americas 2015-2020 ($ millions)
Exhibit 31: Immunohematology market in Americas: Metric analysis for various countries
Exhibit 32: Key takeaway: Immunohematology market in US
Exhibit 33: EMEA: Market overview of immunohematology
Exhibit 34: Number of blood transfusions performed in Europe in 2014 (millions)
Exhibit 35: Immunohematology market in Europe 2015-2020 ($ millions)
Exhibit 36: Immunohematology market in EMEA: Metric analysis for various countries
Exhibit 37: Key takeaway: Immunohematology market in UK
Exhibit 38: APAC: Market overview of immunohematology
Exhibit 39: Immunohematology market in APAC 2015-2020 ($ millions)
Exhibit 40: Immunohematology market in APAC: Metric analysis for various countries
Exhibit 41: Key takeaway: Immunohematology market in China
Exhibit 42: Market impact: Fully automated immunohematology analyzer based on end-users
Exhibit 43: Potential market revenue of immunohematology with estimated number of cord blood units sold worldwide
Exhibit 44: Sales strategies of distributors and companies
Exhibit 45: Impact of drivers
Exhibit 46: Cost of cord blood unit maintenance in private and public blood banks
Exhibit 47: Impact of drivers and challenges
Exhibit 48: Blood banks: Public-private partnership
Exhibit 49: Blood banks: Market impact
Exhibit 50: Companies focusing on immunohematology training to promote marketing and sales
Exhibit 51: Competitive structure analysis of global immunohematology market 2015
Exhibit 52: Competitive landscape analysis of global immunohematology market 2015
Exhibit 53: Global immunohematology market: Market share analysis of vendors 2015
Exhibit 54: Bio-Rad Laboratories: Profile summary
Exhibit 55: Bio-Rad Laboratories: Strength analysis
Exhibit 56: Bio-Rad Laboratories: Growth strategy matrix
Exhibit 57: Bio-Rad Laboratories: Opportunity assessment
Exhibit 58: Grifols: Profile summary
Exhibit 59: Grifols: Strength analysis
Exhibit 60: Grifols: Growth strategy matrix
Exhibit 61: Grifols: Opportunity assessment
Exhibit 62: Immucor: Profile summary
Exhibit 63: Immucor: Strength analysis
Exhibit 64: Immucor: Growth strategy matrix
Exhibit 65: Immucor: Opportunity assessment
Exhibit 66: Ortho Clinical Diagnostics: Profile summary
Exhibit 67: Ortho Clinical Diagnostics: Strength analysis
Exhibit 68: Ortho Clinical Diagnostics: Growth strategy matrix
Exhibit 69: Ortho Clinical Diagnostics: Opportunity assessment
Exhibit 70: Other prominent vendors
  • Packaging Sector Driven By Innovation
    The financial development in numerous emerging nations has significantly influenced the progress of quite a lot of sectors, the packaging industry being one of them. The swell in transport undertakings outfitting to a substantial number of industries such as manufacturing, consumer goods, food and beverages, and others rest essentially on sturdy and resilient packaging solutions [...]
  • Global Eyewear Market To Gain From Increased Demand For Disposable Contact Lenses
    The global eyewear market was worth US$ 102.66 billion in 2015 and is predictable to reach US$ 184.03 billion by 2024. The rising population and upsurge in the number of optical disorders are likely to propel the industry in the near future. Moreover, the increasing cognizance amongst people as regards to the prominence of eye [...]
  • Global mHealth Market To Become A Multi-Billion Dollar Industry By 2020
    The mHealth market is in its embryonic stage and is projected to produce substantial profits with amassed awareness level and encouraging regulatory guidelines particular to the quality and practicality of mobile-based medical devices. The global mHealth market is projected to touch US$ 49.12 billion by 2020 rising at a CAGR of 47.6% from 2013 to 2020. Monitoring services [...]
  • Efficacy of Stand-alone Power Sources Drive The Global Distributed Energy Generation Market
    The global market for distributed energy generation is expected to magnify at a momentous CAGR of 11.4% between 2016 and 2020. The small-scale generation of electricity, oscillating from a few kilowatts to multitudes of megawatts, is denoted as distributed energy generation. In this process, power is usually produced using renewable resources or by generators during consumption. [...]
  • Global Organic Food Market Makes A Mark in Developed Economies
    Buyers throughout the world are becoming more and more health cognizant, which has occasioned in an alteration in their palates and inclinations. The global organic food market was worth US$88.1 billion in 2015 is anticipated to record a CAGR of over 16% between 2015 and 2020. Amongst the various different food products available, the fruits [...]
  • Septicaemia-API Insights, 2017
    Published: 01-Jan-2017        Price: US 1250 Onwards        Pages: 60
    The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have......
  • Hyperkalemia-Pipeline Insights, 2017
    Published: 01-Jan-2017        Price: US 1250 Onwards        Pages: 60
    DelveInsight's, " Hyperkalemia-Pipeline Insights, 2017", report provides in depth insights on the pipeline drugs and their development activities around the Hyperkalemia. The DelveInsight'sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fun......
  • Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017
    Published: 01-Jan-2017        Price: US 2000 Onwards        Pages: 100
    DelveInsight's Report, "Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016", provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) Report is to understand the market and pipeline status of the drugs around the Idiopathic Thrombocy......
  • Bacteremia-Pipeline Insights, 2017
    Published: 01-Jan-2017        Price: US 1250 Onwards        Pages: 60
    DelveInsight's, " Bacteremia-Pipeline Insights, 2017", report provides in depth insights on the pipeline drugs and their development activities around the Bacteremia. The DelveInsight'sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, funding......
  • Thromboembolism-API Insights, 2017
    Published: 01-Jan-2017        Price: US 1250 Onwards        Pages: 60
    The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have......
  • Thrombosis-API Insights, 2017
    Published: 01-Jan-2017        Price: US 1250 Onwards        Pages: 60
    The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have......
  • Hypercalcemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017
    Published: 01-Jan-2017        Price: US 2000 Onwards        Pages: 100
    DelveInsight's Report, "Hypercalcemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016", provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Hypercalcemia Report is to understand the market and pipeline status of the drugs around the Hypercalcemia to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designi......
  • Hypercholesterolemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017
    Published: 01-Jan-2017        Price: US 2000 Onwards        Pages: 100
    DelveInsight's Report, "Hypercholesterolemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016", provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Hypercholesterolemia Report is to understand the market and pipeline status of the drugs around the Hypercholesterolemia to explore the generic development opportunities, licensing opportunities and to gain competitive......
  • Hyperlipidemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017
    Published: 01-Jan-2017        Price: US 2000 Onwards        Pages: 100
    DelveInsight's Report, "Hyperlipidemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016", provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Hyperlipidemia Report is to understand the market and pipeline status of the drugs around the Hyperlipidemia to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on desi......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs